| Multiple Myeloma Research and Treatments | Lifetime | 23 | DE 1 | 99.83 |
| CAR-T cell therapy research | Lifetime | 69 | DE 4 | 99.70 |
| Cytomegalovirus and herpesvirus research | Lifetime | 66 | DE 4 | 99.40 |
| Protein Degradation and Inhibitors | Lifetime | 38 | DE 3 | 99.61 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 114 | DE 13 | 99.37 |
| Antifungal resistance and susceptibility | Lifetime | 111 | DE 4 | 99.31 |
| Neutropenia and Cancer Infections | Lifetime | 80 | DE 8 | 99.05 |
| Fungal Infections and Studies | Lifetime | 133 | DE 3 | 98.98 |
| Cancer Treatment and Pharmacology | Lifetime | 368 | DE 16 | 98.92 |
| Peptidase Inhibition and Analysis | Lifetime | 577 | DE 46 | 98.01 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 893 | DE 70 | 97.89 |
| Polyomavirus and related diseases | Lifetime | 453 | DE 43 | 96.47 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 723 | DE 82 | 96.96 |
| Acute Lymphoblastic Leukemia research | Lifetime | 964 | DE 89 | 96.83 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 782 | DE 25 | 96.39 |
| Infectious Diseases and Mycology | Lifetime | 777 | DE 27 | 92.10 |
| Oral health in cancer treatment | Lifetime | 985 | DE 41 | 84.65 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 15 | DE 2 | 99.76 |
| CAR-T cell therapy research | 2021-2025 | 67 | DE 6 | 99.53 |
| Protein Degradation and Inhibitors | 2021-2025 | 27 | DE 3 | 99.42 |
| Cancer Treatment and Pharmacology | 2021-2025 | 151 | DE 12 | 97.14 |
| Peptidase Inhibition and Analysis | 2021-2025 | 209 | DE 24 | 95.47 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 357 | DE 20 | 94.30 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 633 | DE 43 | 93.79 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 691 | DE 53 | 94.29 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 415 | DE 41 | 90.92 |
| Acute Myeloid Leukemia Research | 2021-2025 | 986 | DE 92 | 92.06 |
| Viral Infectious Diseases and Gene Expression in Insects | 2021-2025 | 283 | DE 44 | 86.96 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 309 | DE 15 | 87.20 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 667 | DE 61 | 89.66 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 835 | DE 71 | 85.92 |
| Chemokine receptors and signaling | 2021-2025 | 174 | DE 31 | 78.15 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 635 | DE 41 | 81.59 |
| Neutropenia and Cancer Infections | 2021-2025 | 756 | DE 51 | 71.31 |
| Dermatological and Skeletal Disorders | 2021-2025 | 257 | DE 20 | 68.45 |
